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Abstract 
The flow of cohesive particles in a model dry powder inhaler is studied using a soft sphere DEM model coupled with a dynamic 
LES CFD model.  Collisions are modeled using a Hertzian model for the normal force, with a DMT model for cohesion, and 
using the model due to Mindlin and Deresiewicz for the tangential force.  Calculations that simulate the inhalation of one dose 
show that small particles leave the inhaler faster than large particles and that large particles sometimes become trapped in a 
recirculation region that is established after the small particles have already left.  The results also show that collisions are not 
important for particle-particle momentum exchange initially but become more important as the particles accelerate.  
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1. Introduction  
For the treatment of lung diseases it is often advantageous to deliver medicines directly to the lung in order to 
obtain local action as well as a quick onset of action.  This may be accomplished using a variety of  devices such as 
nebulizers, pressurized metered-dose inhalers or dry powder inhalers (DPIs).  DPIs are often preferred since they do 
not require any propellant that may be harmful to the environment and since dry formulations tend to be more stable. 
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Fig. 1.  (a) sketch of model DPI; (b) transient air flow rate imposed at the inlet. 
 
In order to deliver drug particles to the lung via inhalation, it is important that the particles are small because 
otherwise they do not reach the lungs.  Particles should ideally have a diameter that is on the order of a few microns, 
though the exact requirement depends also on the particle density and shape.  Because particles in this size range 
tend to be very cohesive and difficult to handle, a DPI typically contains agglomerates that are significantly larger 
than a few microns.  In this work, we consider a so-called carrier-based formulation.  In such a formulation, drug 
particles with a diameter of approximately 1 μm are attached to carrier particles with a diameter of approximately 
100 μm. If the drug product is constructed properly, inhaling the particles through the device causes the drug 
particles to deaggregate from the carrier particles.  
In order to evaluate the performance of a dry powder formulation in a DPI, it is necessary to manufacture the 
formulation, fill it into the DPI, and finally carry out the experiments that are required to evaluate its performance.  
Since this work is time consuming and requires a fair amount of resources, it is of great interest to employ 
computational techniques to support and accelerate drug development.  In addition, the drug substance is often quite 
expensive, particularly at early stages of development when it is also in short supply.  In this work we therefore 
consider the performance of a model DPI using a discrete element - computational fluid dynamics model. 
2. Computational model 
As already mentioned this work considers the flow of a cohesive powder in a model DPI, shown in Fig. 1a, 
modeled using a coupled discrete element – computational fluid dynamics model.  In order to model the flow of air 
realistically, a transient flow rate with a peak flow rate of 70 liter/min, as shown in Fig. 1b, is imposed as a flat 
velocity profile at the inlet.  This peak flow rate is reached in approximately 0.4 s, which roughly corresponds to the 
inhalation profile for a healthy adult. The device has a diameter of 7 mm which implies that the peak flow rate 
corresponds to an average inlet velocity of 30 m/s and a Reynolds number of approximately 1.4×104. The flow can 
thus be expected to undergo a transition from laminar to turbulent during the inhalation process.   In order to model 
the flow behavior in a realistic fashion, the flow of air is modeled using a dynamic large eddy simulation (LES) 
model with a dynamic Germano-Lilly model for the subgrid-scale stress (see e.g. Mallouppas and van Wachem [1]).  
The coupling between the air and particles is modeled using the drag model of Wen and Yu [2] with the expression 
for the drag coefficient put forward by Rowe [3]. 
The particles are modeled using a soft-sphere DEM model that considers translational as well as rotational 
motion.  Particle-particle and particle-wall contacts are resolved and are modeled using a Hertzian model [4] to 
predict the normal force.  The contact force in the tangential direction is modeled according to the theory described 
by Mindlin and Deresiewicz [5].  In the context of the tangential force it is important to point out that it is a result of 
the history of the collision.  The cohesive force between particles is modeled using the DMT model [6].   
The governing equations for the continuous phase are solved using MultiFlow, a fully-coupled, parallelized 
multiphase computational fluid dynamics software based upon the finite-volume method developed by the van 
Wachem group at Imperial College.  MultiFlow uses a second order accurate three-point backward Euler 
discretization for the temporal terms and second order accurate central scheme for the advection terms.   
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Fig. 2. Initial condition for (a) polydisperse particles with diameters from 25 to 100 μm; (b) monodisperse particles with a diameter of 70 μm. 
 
3. Results 
Results are obtained for dose emptying of monodisperse carrier particles with diameters of 50, 70, and 100 μm as 
well as for polydisperse carrier particles with diameters between 25 and 100 μm. In all cases, the numbers of 
particles are chosen to represent 10 mg carrier particles.  The simulations thus include between 104 and 105 particles 
depending on their size.  Calculations are carried out in parallel on 8 CPUs and require an execution time of 
approximately 1 week. 
Fig. 2b shows the initial condition for the monodisperse particles with a diameter of 70 μm.  In order to create 
this initial condition, particles were simply placed in a closed-packed pattern.  For the polydisperse particles, it was 
not possible to arrange the particles in a similar fashion.  Instead, a separate simulation was carried out in order to 
form the heap of particles at the bottom of the inhaler, as shown in Fig. 2a.  Despite these differences in the initial 
conditions, the difference in the time required by the different particles to leave the device is quite small, as shown 
in Fig. 3a.  As also shown in Fig. 3a, small particles leave the device first because they accelerate faster than large 
particles.  Fig. 3a also shows that a small portion of the particles stay in the device for a longer time, which creates a 
tail in the distributions that are shown in Fig. 3a.  This tail in the distribution is a result of particles becoming 
trapped in a recirculation region near the corner of the device that is established after a certain time, as indicated in 
Fig. 3b.  Small particles are not caught in this recirculation zone to the same extent because they have already made 
it some distance downstream by the time it is established. 
At this point it is noted that deaggregation of drug particles from carrier particles is expected to depend on 
particle-particle and particle-wall collisions.  In order to model deaggregation due to particle-particle collisions in a 
simple fashion, measures of particle-particle collisions are calculated by considering the total number of collisions 
as well as the total momentum exchanged in those collisions, as shown in Fig. 4.  Fig. 4 shows that there are many 
collisions initially when particle are close together in the pile, but that little momentum is exchanged in these 
collisions since the particles have very low velocity initially.  Fig. 4 instead shows that the momentum exchange in 
the collisions becomes significant only at a later time when the particles have accelerated.  
Before considering the behavior of a cohesive powder, it is important to point out that lactose-based carrier 
particles with a diameter of 50 micron or larger are not expected to be cohesive.  In order to nevertheless carry out 
simulations for a cohesive powder, for example to model carrier particles that have been coated with cohesive drug 
particles, simulations for carrier particles with a Hamaker constant that has been increased by a factor of 100 are 
carried out.  These simulations show that the pile of particles first slides down the exit channel and that the air flow 
at some later point lifts the pile from the wall, as shown in Fig. 5.  The air then breaks up the pile and disperses the 
particles as they flow out of the device, as also shown in Fig. 5. 
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Fig. 3.  (a) mass left in the inhaler as a function of time for particles with different diameters; (b) image showing particles caught in the 
recirculation zone near the corner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                     
Fig. 4.  (a) the total number of particle-particle collisions as a function of distance downstream from the corner at different points in time; (b) 
the total momentum exchange in particle-particle collisions as a function of distance downstream from the corner at different points in time. 
 
 
 
 
   
 
 
 
 
 
 
    
 
Fig 5.  The motion and break-up of a very cohesive powder. 
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Fig. 6. Sub-model used to study drug particle deaggregation in detailed model of particle-particle collisions; (a) immediately before collision; 
(b) immediately after collision; (b) as particles separate again. 
 
4. Conclusions and future work 
A soft-sphere DEM/CFD model based upon a dynamic large eddy simulation model was developed to study the 
flow of cohesive particles in a model inhaler.  The model was used to study how particles with different diameters 
leave the inhalation device and to obtain a measure of deaggregation by considering particle-particle collisions.  The 
flow of a very cohesive powder was studied in order to simulate carrier particles that have been coated with cohesive 
drug particles. 
In future work, the model that includes cohesion will be improved to include also small drug particles. This 
improved model will then be employed to study collisions between carrier particles with drug substance particles 
attached, as shown in Fig. 6.  Detailed sub-models such as the one shown in Fig. 6 can then be employed to construct 
functions that can be used to determine, based upon e.g. the impact velocity and the Hamaker constant, the fraction 
of drug particles that come off the carrier particle in a collision.  These functions can be included in the full 
simulation to calculate a more accurate measure of deaggregation than the one based simply on the total momentum 
exchanged in the collisions. 
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